In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Remibrutinib results in significant improvement in patients still symptomatic after second-generation H1-antihistamine treatment.

Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC ...

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

An Oakland County adult is the first measles patient in Michigan since July 2024. The Michigan Department of Health and Human ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in the country. This is despite South Africa having the world's biggest ...

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...